NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹428 Cr |
| Mar2023 | ₹439 Cr |
| Mar2022 | ₹363 Cr |
| Mar2021 | ₹369 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹466 Cr | 8.89 | |
| Mar2024 | ₹428 Cr | -2.57 | |
| Mar2023 | ₹439 Cr | 20.87 | |
| Mar2022 | ₹363 Cr | -1.45 | |
| Mar2021 | ₹369 Cr | - | |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,139.4 Cr | 1.2% | 11.8% | 56.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 1.2% |
11.8% |
56.1% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses